Pharmaceutical Technology, Nov 1, 2007 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe
Pharmaceutical Technology, Nov 1, 2007
Articles
Going Mobile
By Richard W. Padula
Seven Reasons Why Pharmaceutical Makers Are Adopting Mobile Technology
Defragmenting GRC: Confidence and Cost-Efficiency in a Time of Chaos
By Brett Curran
The scope and complexity of GRC requirements are expanding so rapidly that businesses are struggling to fulfill them despite an increased willingness on industry's part to apply additional GRC resources.
Tech Talk: A Q&A with Oracle's Arvindh Balakrishnan
By Michelle Hoffman

The senior director of Oracle's Life Sciences Business Unit tackles some of the technical issues regarding regulatory standardization, software integration, and the trend toward virtualization, among other things.

Do you have something to ask Arvindh Balakrishnan? Click here to submit your questions.
The Challenge in Bioprocess Development: From Data to Knowledge
By Gary Montague , Elaine Martin
The senior director of Oracle's Life Sciences Business Unit tackles some of the technical issues regarding regulatory standardization, software integration, and the trend toward visualization, among other things.
Determining LIMS Functionality, Cost, and ROI: System Architecture Strengths and Limitations
By Ron Kasner
Before any information technology solution can be installed, a company must decide whether applications are going to reside on individual computers at each employee's workstation, on servers within or outside of an organization, or on a vendor's website.
The New Biopharmaceutical Blueprint: Service-Oriented Architecture in Manufacturing
By Pieter Deurinck , Jay DiMare , Michael T. Ricci , Kathleen Martin
More than ever, drug makers need to be fleet and flexible—and they need their software to be the same.

ADVERTISEMENT
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
18%
To all process for new products only
13%
To select process for new products only
22%
To select processes for both new and legacy products
22%
Do not use QbD
24%
View Results
Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
FindPharma Custom Search
Featured Jobs

More Jobs
Click here